Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms

    NEXT STORY
    Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
    PREV STORY
    Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ultimovacs Announces Further Positive Topline Results from Phase I UV1 Cancer Vaccine Combination Study in Metastatic Melanoma

    author_avatar
    NASDAQ Market News

    Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News

    Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

    author_avatar
    NASDAQ Market News